You'll See More "Concomitant" Quadruple Therapy for H. pylori
March 2017
You'll see changes in preferred drug regimens for H. pylori.
Triple therapy with a PPI and two antibiotics (Prevpac, etc) will fall out of favor. It's not as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.
Expect to see a shift based on new guidelines...with more use of QUADRUPLE therapy and treating for 14 days instead of 7 to 10 days.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote